Home > Insider Trading > Filing (0001181431-13-001234)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070336	Achillion Pharmaceuticals Inc	ACHN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378586	Gautam Shah	C/O Achillion Pharmaceuticals 300 George Street New Haven CT 06511	Evp And Chief Compliance Ofc.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-12-31	14,899	$1.05	18,024	No	4	M	Direct
Common Stock	Acquisiton	2012-12-31	73,269	$3.10	91,293	No	4	M	Direct
Common Stock	Disposition	2012-12-31	88,168	$8.01	3,125	No	4	S	Direct
Common Stock	Acquisiton	2013-01-02	6,234	$3.28	9,359	No	4	M	Direct
Common Stock	Acquisiton	2013-01-02	20,731	$3.10	30,090	No	4	M	Direct
Common Stock	Disposition	2013-01-02	26,965	$8.40	3,125	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2012-12-31	14,899	$0.00	14,899	$1.05
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2012-12-31	73,269	$0.00	73,269	$3.10
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2013-01-02	6,234	$0.00	6,234	$3.28
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2013-01-02	20,731	$0.00	20,731	$3.10

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-12-15	No	4	M	Direct
114,731	2020-12-16	No	4	M	Direct
8,313	2019-12-18	No	4	M	Direct
94,000	2020-12-16	No	4	M	Direct

Footnotes

This option was granted on December 15, 2008 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
This option was granted on December 16, 2010 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
This option was granted on December 18, 2009 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
The price in column is a weighted average price. The actual sale prices for these transactions ranged from $8.00 to $8.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. within the range.
The price in column is a weighted average price. The actual sale prices for these transactions ranged from $8.30 to $8.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. within the range.